Wordt geladen...
DIPG-75. INTERSECTION OF EPIGENETICS AND IMMUNITY IN DIPG
Improved therapy for DIPG represents an urgent unmet clinical need. No meaningful improvement has been made in over 30 years, with palliative radiation leading to a median survival of just 1 year. Immune checkpoint inhibitors are an important new therapeutic modality, showing success in many adult c...
Bewaard in:
| Gepubliceerd in: | Neuro Oncol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012243/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.167 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|